BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
6/20/18 Novo Nordisk (NVO) Oral Semaglutide for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
6/20/18 Amneal Pharmaceuticals (AMRX) Rytary for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
6/20/18 CytoDyn (CYDY) PRO 140 for Graft vs. Host Disease (GVHD) Subscribers Only Subscribers Only Subscribers Only
6/20/18 argenx (ARGX) Efgartigimod for Pemphigus Vulgaris Subscribers Only Subscribers Only Subscribers Only
6/19/18 Sarepta (SRPT) Microdystrophin Gene Therapy Program (NCH) for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
06/20/18 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
06/21/18 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
06/21/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/21/18 Subscribers Only Subscribers Only Trial Data - Updated Results
06/22/18 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Brief